Skip to main content
Article thumbnail
Location of Repository

Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia

By Maria Luiza Macedo Silva, Maria do Socorro Pombo-de-Oliveira, Susana C Raimondi, Hasmik Mkrtchyan, Eliana Abdelhay, Amanda Faria de Figueiredo, Mariana Tavares de Souza, Daniela Ribeiro Ney Garcia, Eliane Maria Soares de Ventura, Adriana Martins de Sousa and Thomas Liehr
Topics: Commentary
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2653040
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2002). A: Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
    2. (2000). A: The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome. Cancer Genet Cytogenet
    3. (2005). An International System for Human Cytogenetic Nomenclature. Edited by: Shaffer LG, Tommerup
    4. (2008). B: Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood
    5. (2006). Children's Oncology Group (COG): A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood
    6. (2002). Comparative M-FISH and CGH analyses in sensitive and drug-resistant human T-cell acute leukemia cell lines. Cytogenet Genome Res
    7. (2004). Crispino JD: Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome. Blood
    8. (1985). Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med
    9. (2006). Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. Early Hum Dev
    10. (2003). DR: A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia
    11. (2003). Izraeli S: Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood
    12. (1999). LC: Trisomy 8 as a secondary genetic change in acute megakaryoblastic leukemia associated with Down's syndrome. Leukemia
    13. Leukemia diagnosis 2nd edition.
    14. (2003). Liehr T: Multitude multicolor chromosome banding (mMCB) – a comprehensive one-step multicolor FISH banding method. Cytogenet Genome Res
    15. (1992). Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res
    16. (2008). T: Banding and molecular cytogenetic studies detected a CBFB-MYH11 fusion gene that appeared as abnormal chromosomes 1 and 16 in a baby with acute myeloid leukemia FAB M4-Eo. Cancer Genet Cytogenet
    17. (2002). U: Microdissection based high resolution multicolor banding for all 24 human chromosomes.
    18. (2004). Vyas P: Natural history of GATA1 mutations in Down syndrome. Blood
    19. (2005). Zipursky A: Origins of leukaemia in children with Down syndrome. Nat Rev Cancer

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.